Finelli A - Search Results

1

Neoadjuvant Cabazitaxel plus Abiraterone/Leuprolide Acetate in Patients with High-Risk Prostate Cancer: ACDC-RP Phase II Trial.

Fleshner NE, Sayyid RK, Hansen AR, Chin JLK, Fernandes R, Winquist E, van der Kwast T, Sweet J, Lajkosz K, Kenk M, Hersey K, Veloso R, Berlin D, Herrera-Caceres JO, Sridhar S, Moussa M, Finelli A, Hamilton RJ, Kulkarni GS, Zlotta AR, Joshua AM. Fleshner NE, et al. Among authors: finelli a. Clin Cancer Res. 2023 Oct 2;29(19):3867-3874. doi: 10.1158/1078-0432.CCR-23-0731. Clin Cancer Res. 2023. PMID: 37439809 Clinical Trial.

2

Evidence for a biopsy derived grade artifact among larger prostate glands.

Kulkarni GS, Al-Azab R, Lockwood G, Toi A, Evans A, Trachtenberg J, Jewett MA, Finelli A, Fleshner NE. Kulkarni GS, et al. Among authors: finelli a. J Urol. 2006 Feb;175(2):505-9. doi: 10.1016/S0022-5347(05)00236-3. J Urol. 2006. PMID: 16406982

3

Surgical wait times for patients with urological cancers: a survey of Canadian surgeons.

Fleshner N, Dranitsaris G, Finelli A, Tsihlias J, Bell D, Gleave M; Canadian surgical wait times (SWAT) initiative. Fleshner N, et al. Among authors: finelli a. Can J Urol. 2006 Jun;13 Suppl 3:3-13. Can J Urol. 2006. PMID: 16818006

4

The impact of introducing laparoscopic radical prostatectomy on surgical wait times for prostate cancer.

Hamilton RJ, Finelli A. Hamilton RJ, et al. Among authors: finelli a. Can J Urol. 2006 Jun;13 Suppl 3:25-9. Can J Urol. 2006. PMID: 16818009

5

An efficient solution to the retained Foley catheter.

Hamilton RJ, Jewett MA, Finelli A. Hamilton RJ, et al. Among authors: finelli a. Urology. 2006 Nov;68(5):1109-11. doi: 10.1016/j.urology.2006.06.012. Urology. 2006. PMID: 17113905

6

Laparoscopic retroperitoneal lymph node dissection for nonseminomatous germ-cell tumors: current status.

Hamilton RJ, Finelli A. Hamilton RJ, et al. Among authors: finelli a. Urol Clin North Am. 2007 May;34(2):159-69; abstract viii. doi: 10.1016/j.ucl.2007.02.007. Urol Clin North Am. 2007. PMID: 17484921 Review.

7

Clinical predictors of Gleason score upgrading: implications for patients considering watchful waiting, active surveillance, or brachytherapy.

Kulkarni GS, Lockwood G, Evans A, Toi A, Trachtenberg J, Jewett MA, Finelli A, Fleshner NE. Kulkarni GS, et al. Among authors: finelli a. Cancer. 2007 Jun 15;109(12):2432-8. doi: 10.1002/cncr.22712. Cancer. 2007. PMID: 17497649 Free article.

8

Delay in the progression of low-risk prostate cancer: rationale and design of the Reduction by Dutasteride of Clinical Progression Events in Expectant Management (REDEEM) trial.

Fleshner N, Gomella LG, Cookson MS, Finelli A, Evans A, Taneja SS, Lucia MS, Wolford E, Somerville MC, Rittmaster R; REDEEM Study Group. Fleshner N, et al. Among authors: finelli a. Contemp Clin Trials. 2007 Nov;28(6):763-9. doi: 10.1016/j.cct.2007.05.006. Epub 2007 May 29. Contemp Clin Trials. 2007. PMID: 17573244

9

Optimal management of high-risk T1G3 bladder cancer: a decision analysis.

Kulkarni GS, Finelli A, Fleshner NE, Jewett MA, Lopushinsky SR, Alibhai SM. Kulkarni GS, et al. Among authors: finelli a. PLoS Med. 2007 Sep;4(9):e284. doi: 10.1371/journal.pmed.0040284. PLoS Med. 2007. PMID: 17896857 Free PMC article.

10

Extended pattern prostate biopsy does not minimize the volume-grade bias in prostate cancer detection.

Al-Ghamdi AM, Lockwood G, Toi A, Kulkarni GS, Evans A, Finelli A, Zlotta AR, Fleshner N. Al-Ghamdi AM, et al. Among authors: finelli a. J Urol. 2008 Apr;179(4):1332-4. doi: 10.1016/j.juro.2007.11.067. Epub 2008 Mar 4. J Urol. 2008. PMID: 18289588

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

491 results

Search Page